Tested on Gulf Medical Boards (DHA, SMLE, MOH & HAAD)
Clinical calculations and diagnostic scoring systems like Atherogenic Index of Plasma (AIP) frequently appear on Prometric exams. Master high-yield clinical vignettes with instant AI-powered pathophysiology rationales.
What is the Atherogenic Index of Plasma (AIP)?
The Atherogenic Index of Plasma (AIP) is an evidence-based clinical decision rule engineered to quantify diagnostic probability, stratify clinical severity, and guide therapeutic decision-making in cardiology practice. The Atherogenic Index of Plasma (AIP) is calculated as the base-10 logarithm of the ratio of plasma triglycerides to high-density lipoprotein (HDL) cholesterol (when measured in mmol/L). It is a strong marker for predicting the risk of atherosclerosis and coronary heart disease, reflecting the true relationship between protective and atherogenic lipoproteins. Clinical scoring tools like Atherogenic Index of Plasma (AIP) are essential in acute and outpatient management, enabling clinicians to objectively differentiate between low-risk candidates suitable for conservative therapy and high-risk patients requiring urgent interventions. Verified against current 2026 clinical standards, this tool is extensively tested on Gulf health authority licensing exams including DHA (Dubai), SMLE (Saudi Arabia), MOH, HAAD/DOH (Abu Dhabi), OMSB (Oman), and QCHP (Qatar).
💡Clinical Pearls & Diagnostic Utility
AIP correlates closely with LDL particle size (an inversely proportional relationship). A high AIP indicates a higher proportion of small, dense LDL particles, which are highly atherogenic.
Formula & Calculation Parameters
The mathematical equation and clinical variables required to calculate Atherogenic Index of Plasma (AIP):
Score Interpretation & Clinical Stratification
| Score Range | Clinical Interpretation | Risk Tier |
|---|---|---|
| ≤ 0.11 | Low Risk | green |
| 0.11 – 0.21 | Intermediate Risk | yellow |
| ≥ 0.21 | High Risk | red |
When to Exercise Caution
While a powerful prognostic marker, it is not yet incorporated into all major societal guidelines (like the ACC/AHA pooled cohort equations) for prescribing statins.
Clinical Review Board
Dr. Muhammad Nouman, MBBS
Capital Medical University | PMDC Reg No: 117744-P
Clinical Audit Status
✓ Verified for 2026 Guidelines
Last updated: 2026-08-07
Peer-Reviewed Medical Literature
- •Dobiásová M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001;34(7):583-588.
Related Cardiology Calculators & Scoring Tools
Explore related clinical calculators, risk stratification indexes, and diagnostic scoring algorithms in Cardiology:
Wells' Criteria for DVT
Calculates the pre-test probability of Deep Vein Thrombosis.
CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk
Calculates stroke risk for patients with atrial fibrillation.
HAS-BLED Score
Assesses bleeding risk in patients on anticoagulation therapy.
qSOFA Score
Quick Sequential Organ Failure Assessment for sepsis risk.
Centor Score
Estimates probability of streptococcal pharyngitis.
Ideal Body Weight (IBW)
Calculate ideal body weight using the Devine formula.